Drugs / MGCD290
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01497223 | Dec 2011 → Apr 2013 | vulvovaginal candidiasis | MethylGene Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MGCD290 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01497223 ↗ |
| Route | Oral | “Oral Administration of MGCD290” NCT01497223 ↗ |